UNSPSC 51192017: Pegloticase

This classification denotes an uricase covalently attached to polyethylene glycol and immobilized enzyme with the chemical formula C1549H2430N408O448S8, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier R581OT55EA, chemically known as des-(1-6)-(7-threonine,46-threonine,291-lysine,301-serine)uricase (ec 1.7.3.3, urate oxidase) but generally known as Pegloticase. European Medicines Agency schedules Pegloticase in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB32159.

The term Pegloticase is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 22, No. 3, 2008, List 60.) As of Q4 2014, PEGLOTICASE remains the US FDA Preferred Term for this commodity.

UNSPSC 51192017 Pegloticase (Commodity) shows little relevant recent state and local procurement activity. The three opportunities tagged with this code—a District Attorney's Office Dog procurement from Washington County, Oregon; athletic training services for Tucson Fire and Police Departments; and medical aid supplies for Tampa Fire Rescue—are unrelated to pegloticase, a urate-lowering pharmaceutical used to treat chronic gout. The mismatch suggests the code has been applied incorrectly to these solicitations or serves as a default placeholder in state and local procurement systems rather than reflecting actual buying patterns for the pharmaceutical itself.

Without substantive recent opportunities aligned to the code's actual scope, business development professionals should treat this code as inactive in state and local procurement at present. If your firm supplies pegloticase or related pharmaceutical products to state and local health departments, hospitals, or public employee benefit programs, monitor this code periodically for procurement resurgence, but do not prioritize pursuit against current market signals.